Houston – Texas Medical Center has announced the opening of its accelerator program, TMCx, one of the core components of the Texas Medical Center’s Innovation Institute and the first step in the Texas Medical Center’s long-term plans to become one of the world’s premiere life science commercialization clusters.
TMCx, housed in a 100,000-square-foot facility in a former Nabisco plant on Holcombe Boulevard, is designed to catapult the development of early-stage companies.
“As part of a strategic planning process, leadership from across the TMC identified innovation and commercialization as the top priority across the medical center. With over $3.7 billion in research grant funding in the last five years, translating research to commercialization is the single greatest opportunity for the Texas Medical Center,” said Robert C. Robbins, M.D., President and Chief Executive Officer, Texas Medical Center.
TMCx companies have access to the largest collection of top physicians, scientists and business expertise on one campus, which serves over 7.2 million patients annually. In addition, TMCx companies will participate in an accelerator without the financial burden or requirement to accept dilutive funding.
“The Texas Medical Center accelerator (TMCx) will focus on the critical components, a thoughtfully vetted business model, securing intellectual property, advancing technologies through validation and building management teams,” said William F. McKeon, Chief Operating Officer, Texas Medical Center. “Quite simply, we want the highest caliber of talent and technologies that impact health.”